Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.
2.

Ximelagatran (AstraZeneca).

Hopfner R.

Curr Opin Investig Drugs. 2002 Feb;3(2):246-51. Review.

PMID:
12020054
3.

ZD-9331 AstraZeneca.

Niculescu-Duvaz I.

Curr Opin Investig Drugs. 2000 Sep;1(1):141-9. Review.

PMID:
11249590
4.

ZD-0892 AstraZeneca.

Ohbayashi H.

Curr Opin Investig Drugs. 2000 Oct;1(2):227-9.

PMID:
11249578
5.

Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals.

Collette L, Burzykowski T, Carroll KJ, Newling D, Morris T, Schröder FH; European Organisation for Research and Treatment of Cancer; Limburgs Universitair Centrum; AstraZeneca Pharmaceuticals.

J Clin Oncol. 2005 Sep 1;23(25):6139-48.

PMID:
16135480
6.

Cangrelor AstraZeneca.

Chattaraj SC.

Curr Opin Investig Drugs. 2001 Feb;2(2):250-5. Review.

PMID:
11816839
7.

The statin wars: why AstraZeneca must retreat.

[No authors listed]

Lancet. 2003 Oct 25;362(9393):1341. No abstract available.

PMID:
14585629
8.

NO-naproxen (AstraZeneca).

Monck N.

IDrugs. 2003 Jun;6(6):593-9. Review.

PMID:
12811683
9.

Robalzotan AstraZeneca.

Mucke HA.

Curr Opin Investig Drugs. 2000 Oct;1(2):236-40.

PMID:
11249580
11.

ZD-0473 AstraZeneca.

Hay MP.

Curr Opin Investig Drugs. 2000 Oct;1(2):263-6.

PMID:
11249584
12.

AZD-2563 AstraZeneca.

Johnson AP.

Curr Opin Investig Drugs. 2002 Jun;3(6):848-52. Review.

PMID:
12137402
13.

Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.

Kogej T, Blomberg N, Greasley PJ, Mundt S, Vainio MJ, Schamberger J, Schmidt G, Hüser J.

Drug Discov Today. 2013 Oct;18(19-20):1014-24. doi: 10.1016/j.drudis.2012.10.011. Epub 2012 Nov 3. Review.

PMID:
23127858
14.

ZD-6474. AstraZeneca.

Bates D.

Curr Opin Investig Drugs. 2003 Dec;4(12):1468-72. Review.

PMID:
14763134
15.

AstraZeneca takes legal action to delay generic quietiapine in US.

Hawkes N.

BMJ. 2012 Mar 15;344:e2099. doi: 10.1136/bmj.e2099. No abstract available.

PMID:
22422864
16.

ZD-1839 (AstraZeneca).

Norman P.

Curr Opin Investig Drugs. 2001 Mar;2(3):428-34.

PMID:
11575718
17.

Fulvestrant (AstraZeneca).

Johnston SR.

Curr Opin Investig Drugs. 2002 Feb;3(2):305-12. Review.

PMID:
12020064
18.

Molecular pathology in oncology--the AstraZeneca perspective.

Campbell DA, Carmichael J, Chopra R.

Pharmacogenomics. 2004 Dec;5(8):1167-73.

PMID:
15584883
19.

Teva v. AstraZeneca and secret prior art under 102(g)(2).

Lee S, Knierim M.

Nat Biotechnol. 2012 Sep;30(9):831-3. doi: 10.1038/nbt.2353. No abstract available.

PMID:
22965051

Supplemental Content

Support Center